BRPI0715298A2 - Compostos substuídos de tetrahidropirrolipiperazina tendo afinidade com o canal kcnq2/3 k+ e sua aplicação em medicamentos. - Google Patents

Compostos substuídos de tetrahidropirrolipiperazina tendo afinidade com o canal kcnq2/3 k+ e sua aplicação em medicamentos.

Info

Publication number
BRPI0715298A2
BRPI0715298A2 BRPI0715298-1A2A BRPI0715298A BRPI0715298A2 BR PI0715298 A2 BRPI0715298 A2 BR PI0715298A2 BR PI0715298 A BRPI0715298 A BR PI0715298A BR PI0715298 A2 BRPI0715298 A2 BR PI0715298A2
Authority
BR
Brazil
Prior art keywords
tetrahydropyrolipiperazine
substructed
kcnq2
affinity
compounds
Prior art date
Application number
BRPI0715298-1A2A
Other languages
English (en)
Inventor
Beatrix Merla
Thomas Christoph
Stefan Oberboesch
Klaus Schiene
Gregor Bahrenberg
Robert Frank
Sven Kuehnert
Wolfgang Schroeder
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of BRPI0715298A2 publication Critical patent/BRPI0715298A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0715298-1A2A 2006-10-17 2007-10-16 Compostos substuídos de tetrahidropirrolipiperazina tendo afinidade com o canal kcnq2/3 k+ e sua aplicação em medicamentos. BRPI0715298A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006049452A DE102006049452A1 (de) 2006-10-17 2006-10-17 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
PCT/EP2007/008957 WO2008046582A1 (de) 2006-10-17 2007-10-16 Substituierte tetrahydropyrrolopyrazin-verbindungen mit affinität zum kcnq2/3 k+ kanal und deren verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
BRPI0715298A2 true BRPI0715298A2 (pt) 2014-10-29

Family

ID=39125609

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715298-1A2A BRPI0715298A2 (pt) 2006-10-17 2007-10-16 Compostos substuídos de tetrahidropirrolipiperazina tendo afinidade com o canal kcnq2/3 k+ e sua aplicação em medicamentos.

Country Status (17)

Country Link
US (3) US7625900B2 (pt)
EP (2) EP2112993A1 (pt)
JP (1) JP5256203B2 (pt)
KR (1) KR20090084873A (pt)
CN (1) CN101547925A (pt)
AU (1) AU2007312557B2 (pt)
BR (1) BRPI0715298A2 (pt)
CA (1) CA2666647A1 (pt)
CO (1) CO6160331A2 (pt)
DE (1) DE102006049452A1 (pt)
EC (1) ECSP099320A (pt)
IL (1) IL198073A (pt)
MX (1) MX2009004108A (pt)
NO (1) NO20091509L (pt)
NZ (1) NZ576021A (pt)
RU (1) RU2469037C2 (pt)
WO (2) WO2008046581A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2350093E (pt) * 2008-10-24 2012-11-02 Gruenenthal Gmbh 4,5,6,7-tetra-hidrotienopiridinas substituídas como moduladores de kcnq2/3 para tratamento da dor, epilepsia e incontinência urinária
US8367700B2 (en) 2008-12-17 2013-02-05 Gruenenthal Gmbh Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
US20110301143A1 (en) * 2009-02-23 2011-12-08 Elise Isabel Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
TWI504395B (zh) 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
NZ604745A (en) 2010-08-27 2015-01-30 Gruenenthal Chemie Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
EP2609086B1 (en) 2010-08-27 2015-02-25 Grünenthal GmbH Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
JP5887346B2 (ja) 2010-08-27 2016-03-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｋｃｎｑ２／３調節因子としての置換キノリン−３−カルボキサミド
US8470852B2 (en) 2010-08-27 2013-06-25 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
MX2013002295A (es) 2010-09-01 2013-05-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
KR101820645B1 (ko) 2010-10-20 2018-01-22 그뤼넨탈 게엠베하 Ｋｃｎｑ２／３ 조절제로서의 치환된 ６­아미노­니코틴아미드
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
WO2012061698A2 (en) 2010-11-05 2012-05-10 Senomyx, Inc. Compounds useful as modulators of trpm8
CN102229610B (zh) * 2011-04-22 2014-10-29 中山大学 一种光学纯手性1,2,3,4-四氢吡咯并[1,2-a]吡嗪化合物的合成方法
AU2013248638A1 (en) 2012-04-18 2014-12-04 Grünenthal GmbH Substituted 4-aminobenzamides as KCNQ2/3 modulators
JP6033403B2 (ja) 2012-04-18 2016-11-30 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｋｃｎｑ２／３調節因子としてのｏｈ含有基を有する置換６−アミノ−ニコチンアミド類
AU2013351551A1 (en) 2012-11-28 2015-07-16 Grunenthal Gmbh Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2013351550A1 (en) 2012-11-28 2015-07-16 Grünenthal GmbH Specific carboxamides as KCNQ2/3 modulators
AU2014365915C1 (en) * 2013-12-19 2019-04-04 Merck Patent Gmbh Tetrahydro-tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
CN110709523B (zh) * 2017-04-12 2023-07-11 豪夫迈·罗氏有限公司 使用经pictet spengler反应获得的加标签的核苷的测序反应方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188389A (en) * 1978-11-03 1980-02-12 Ayerst Mckenna & Harrison, Inc. 1,2,3,4-Tetrahydropyrrolo(1,2-A)pyrazines
TW224974B (pt) * 1991-07-02 1994-06-11 Hoffmann La Roche
EP0572863A1 (de) * 1992-06-05 1993-12-08 F. Hoffmann-La Roche Ag ZNS Pyrazinoindole
US5378846A (en) * 1993-06-11 1995-01-03 Russian-American Institute For New Drug Development 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
CA2466243A1 (en) * 2001-09-19 2003-03-27 Aventis Pharma S.A. Indolizines as kinase protein inhibitors
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
SE524324C2 (sv) * 2002-04-20 2004-07-27 Sqs Ab Förfarande och anordning vid ett värdeutrymme
PL376056A1 (en) * 2002-09-27 2005-12-12 Janssen Pharmaceutica N.V. 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
US7247628B2 (en) * 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US8362264B2 (en) * 2003-08-22 2013-01-29 Dendreon Corporation Compositions and methods for the treatment of disease associated with Trp-p8 expression
US20090093463A1 (en) * 2004-11-02 2009-04-09 Agouron Pharmaceuticals Inc. Novel compounds of substituted and unsubtituted adamantyl amides

Also Published As

Publication number Publication date
JP5256203B2 (ja) 2013-08-07
US20090258880A1 (en) 2009-10-15
NZ576021A (en) 2011-03-31
IL198073A0 (en) 2009-12-24
US7625900B2 (en) 2009-12-01
US20100004252A1 (en) 2010-01-07
WO2008046582A1 (de) 2008-04-24
CN101547925A (zh) 2009-09-30
EP2112993A1 (de) 2009-11-04
NO20091509L (no) 2009-05-28
CA2666647A1 (en) 2008-04-24
US7879858B2 (en) 2011-02-01
RU2469037C2 (ru) 2012-12-10
IL198073A (en) 2013-03-24
AU2007312557B2 (en) 2013-06-13
CO6160331A2 (es) 2010-05-20
KR20090084873A (ko) 2009-08-05
AU2007312557A8 (en) 2009-06-25
JP2010506869A (ja) 2010-03-04
RU2009118491A (ru) 2010-11-27
EP2144913A2 (de) 2010-01-20
DE102006049452A1 (de) 2008-05-08
ECSP099320A (es) 2009-06-30
AU2007312557A1 (en) 2008-04-24
MX2009004108A (es) 2009-04-28
WO2008046581A2 (de) 2008-04-24
US8017772B2 (en) 2011-09-13
WO2008046581A3 (de) 2008-06-12
US20080167315A1 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
BRPI0715298A2 (pt) Compostos substuídos de tetrahidropirrolipiperazina tendo afinidade com o canal kcnq2/3 k+ e sua aplicação em medicamentos.
BRPI0717367A2 (pt) Di-hidropirazolonas substituídas e sua aplicação.
BRPI0716354A2 (pt) "composiÇço e mÉtodo"
FR2908042B1 (fr) Ensemble d'intubation monocanaliculonasal et/ou monocanaliculaire,notamment pour l'imperforation lacrymonasale.
HUP0500143A2 (en) Real-time 3d nonlinear microscope measuring system and its application
MA29090B1 (fr) Composes inhibiteurs de la phosphorylase du glycogene et compositions pharmaceutiques les comprenant
FR2882054B1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
BRPI0714539A2 (pt) "formas farmacêuticas"
IL194550A (en) Isolated antibodies or their fragments that bind to human protein tyrosine phosphate in a cell, their pharmaceutical preparations and their use
BRPI0815578A2 (pt) Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo.
DK2046715T3 (da) Substituerede 1,3-diphenylpropanderivater, præparater og anvendelser deraf
FR2898636B1 (fr) Structure de queue-d'aronde de soufflante.
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
FR2900549B1 (fr) Ensemble de conditionnement et d'application
BRPI0808246A2 (pt) "fralda descartável".
FI20055150A (fi) Sakeuden muuttaminen ja mittaaminen
BRPI0720333A2 (pt) "conexão de tubulação, conexão de tubulação roscada e mancal estampado"
PT1513836E (pt) Derivados de piperazinilacilpiperidina, sua preparacao e sua aplicacao em terapeutica
BRPI0822223A2 (pt) Derivados de imidazo [1,2-alfa] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica
BRPI1011822A2 (pt) "compostos de 3-substituída-8-substituída-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-ona e sua aplicação"
FR2896154B1 (fr) Composition cosmetique ou dermatologique et son utilisation
BRPI0615630A2 (pt) composição farmacêutica, e, uso de sertindol
BRPI0716374A2 (pt) "dispositivos médicos"
BRPI0922908A2 (pt) "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste".
BRPI0718735A2 (pt) Sensor de posição de cilindro e cilindro incorporando o mesmo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.